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Summary
Methylation analysis with probe PW71 (D15S63) is an
established procedure to test patients suspected of having
Prader-Willi syndrome or Angelman syndrome. Using
this test, we have identified a 28-kb deletion spanning
D15S63 in five independent families. Sequence analysis
revealed identical breakpoints in all the families. The
haplotype data are compatible with a common ancestral
origin of the deletion in at least two families. The de-
letion was not found in 1,000 unrelated controls. Al-
though the deletion maps within the imprinting-center
region, neither maternal nor paternal inheritance of the
deletion appears to affect imprinting in proximal 15q.
We conclude that the deletion is a rare neutral variant
that can lead to false-positive results in the PW71-meth-
ylation test.
Introduction
Prader-Willi syndrome (PWS [MIM 176270]) and An-
gelman syndrome (AS [MIM 105830]) are distinct neu-
rogenetic disorders that are caused by a deficiency of
imprinted gene expression from the paternal or maternal
chromosome 15q11–q13, respectively (for review, see
Nicholls et al. 1998). At the molecular level, the paternal
and maternal copies of the imprinted PWS/AS region
can be distinguished by DNA methylation, DNA repli-
cation, and gene expression. Parent-of-origin–specific
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DNA methylation can be used to confirm the clinical
diagnosis of patients with either PWS and AS who have
a deletion of 15q11–q13, uniparental disomy, or an im-
printing defect. Imprinting defects can result from an
imprinting-center (IC) mutation (Buiting et al. 1995; Sai-
toh et al. 1996; Ohta et al. 1999a, 1999b) or can occur
spontaneously (Buiting et al. 1998; Ohta et al. 1999b).
For methylation analysis, genomic DNA is digested with
methylation-sensitive restriction enzymes and is ana-
lyzed by Southern blot hybridization or PCR (Dittrich
et al. 1992, 1996a; Sutcliffe et al. 1994; Glenn et al.
1996; Chotai and Payne 1998) or is subjected to bisulfite
treatment and methylation-specific PCR (Kosaki et al.
1997; Kubota et al. 1997; Zeschnigk et al. 1997). On
the basis of extensive data obtained by methylation anal-
ysis of PWS and AS patients with PW71 (D15S63) and
SNRPN probes, the ASHG/ACMG Test and Technology
Transfer Committee (1996) has established this analysis
as a scientifically and clinically valid test. Using probe
PW71, we have identified a rare, 28-kb deletion that can
confound routine diagnostic testing of patients.
Patients, Material, and Methods
Patients
Family B.—The index patient had a birth weight of
2.3 kg. Microcephaly was noted at birth, and severe
developmental delay was clear from the early neonatal
period. She developed no speech. Epilepsy started at age
8 years. At age 26 years, her height and head circum-
ference were below the 3d centiles. Her dysmorphic ap-
pearance included deep-set eyes and a prominent mid-
face and upper jaw, but no prominence of the lower jaw.
She had normal secondary sexual characteristics. She
walked with a wide-based gait but did not have jerky
movements or episodes of abnormal laughter.
Family 221.—The index patient is a 5-year-old boy.
He was born with no problems after normal pregnancy;
birth weight was 3 kg. He has mental developmental
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Figure 1 PW71-methylation analysis in the family of patientWe.
Normal individuals typically have a methylated maternal band of 8
kb and an unmethylated paternal band of 6.4 kb. The patient lacks
both bands, whereas his healthy brothers and their mother lack
the maternal band. del = 28-kb deletion; DEL = large deletion of
15q11–q13.
delay and problems in communication and language,
and there are bursts of laughter. He also suffered from
infantile spasm and stereotypic movements. He has a
normal head circumference, a normal computed-tomo-
graphy scan, and a normal magnetic resonance imaging
of the brain.
Family 63.—The index patient is the sister of a girl
with PWS. From the first session of genetic counseling,
it was only noted that she has mental retardation (MR)
and infantile spasm. Since the parents were not interested
in further studies, a reexamination of this patient was
not possible.
Family We.—The index patient is a 14-year-old boy
with PWS. He has several clinical features typical of
PWS, such as neonatal muscular hypotonia, feeding
problems in the first period after birth, kryptorchidism,
and hypopigmentation but lacks overt obesity.
Family P.—The 7-year-old index patient was first sus-
pected of having AS. This diagnosis could not be con-
firmed by further clinical examinations. The patient has
MR, features of autism, and delayed development of
speech.
Subcloning of the Junction-Fragment and Deletion-
Breakpoint Regions
An aliquot of genomic DNA (50 mg) from individual
HW was completely digested with HindIII and was size
fractionated on a 10%–40% sucrose gradient. The frac-
tion containing the 15-kbHindIII junction fragment was
identified through Southern blot hybridization with
probe 71.19.12HR. An aliquot of this fraction (400 ng
of DNA) and 1 mg of HindIIIXbaI-digested Lambda
Dash II DNA (Stratagene) were ligated overnight with
T4 DNA ligase. The ligation products were packaged
in vitro with the Gigapack II Gold packaging extract
(Stratagene), to yield a total of plaque-form-44.5# 10
ing units on host XL1-Blue MRA (P2). Approximately
400,000 plaques were screened with probe 71.19.12HR,
and three positive plaques were obtained. After one
round of plaque purification, phage DNA was isolated
by standard methods. One phage (lHW42) was positive
for both probes—71.19.12HR (centromere) andYR9AB
(telomere)—that flank the breakpoint and that therefore
are likely to contain the 15-kb HindIII junction frag-
ment. Both 0.9- and 0.8-kb BglII fragments of the phage
insert, termed “HWAF1” and “HWAF2,” respectively,
were subcloned into pT7T3-18U vector DNA (Phar-
macia) and were sequenced.
The 2.5-kb BamHI/BglII fragment of clone L48.19I
was termed “HWNFT” and represents the normal telo-
meric genomic breakpoint region. The 3.6-kb BglII/PstI
fragment of clone 71.19.13 was termed “HWNFC” and
represents the normal centromeric genomic breakpoint
region. HWNFT was subcloned into BamHI-digested
pT7T3-18U vector DNA, and HWNFC was subcloned
into BamHI/PstI-digested pT7T3-18U vector DNA.
Both clones were partially sequenced.
DNA Sequence Analysis
Plasmid DNA was isolated from 1.5-ml bacterial cul-
tures by use of the QIAscreen procedure (Diagen) and
was dissolved in 20 ml of water. PCR products were
purified with Microcon-100 microconcentrators (Ami-
con). DNA was sequenced with fluorescence-tagged
dideoxynucleotides and the Taq cycle sequencing pro-
cedure (Applied Biosystems), with use of one of the fol-
lowing primers: M13/pUC reverse and sequencing
primer, primer HWs 5′-AGT ATG ATT CAG AAG GCT
GG-3′ (annealing temperature, 58C) and primer HWp
5′-TCT ATG GAT TGC AAA AGT TG-3′ (annealing
temperature, 54C). Sequencing reactions were analyzed
on an Applied Biosystems Automatic DNA Sequencer,
model 377.
PCR Analysis of the Deletion-Junction Fragment
PCR conditions were as follows: 50 ng genomic DNA
were added to a 50-ml reaction volume containing 200
mM each dNTP, 1 mM each primer, 2.5 U AmpliTaq, 1.5
mM MgCl2, 50 mM KCl, 10 mM Tris-HCl pH 8.3, and
0.1% gelatin. PCR was performed in a GeneAmp 9600
thermal cycler (PE Biosystems), with an initial denatur-
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Figure 2 Haplotype analysis with chromosome 15–specific microsatellite markers. The lociD15S543,D15S817,D15S128, andD15S1234
(centromere to telomere) map within the PWS/AS region. Common alleles are boxed.
ation for 5 min at 94C. Thirty-five cycles were run,
with denaturation for 15 s at 94C, annealing for 15 s
at a primer-specific temperature, and elongation for 30
s at 72C. The final elongation was for 5 min at 72C.
The annealing temperature for primers HWs and HWp
was 54C.
For the screening of unrelated individuals, DNA sam-
ples from 10 individuals each were pooled. Aliquots of
these pools (250 ng DNA) were used for PCRwith prim-
ers HWs and HWp. As a positive control, a primer
pair—OS1-860u (5′-CAG CAG GAG AAT ATG CAG-
3′) and OS1-979l (5′-TGG CAG TAA GTG TTT ATC
TGG-3′)—specific for a locus on chromosome 8q was
included in the PCR. By including DNA from themother
of patient We in one pool, we established that the screen-
ing assay was sensitive enough to detect 1 deletion car-
rier among 10 individuals.
DNA Methylation and Southern Blot Analysis
Genomic DNA was purified from whole blood, ac-
cording to standard methods. Aliquots of the DNA (2
mg) were digested with the appropriate restriction en-
zyme. Fragments were separated by gel electrophoresis
and were transferred to Biodyne A nylon membranes
(PALL). Blots were hybridized as described elsewhere
(Buiting et al. 1998).
Genotyping
Microsatellite analysis was performed with the
following fluorochromed markers from proximal
15q11–q13: D15S543, D15S817, D15S128, and
D15S1234. Amplification products were analyzed with
the A 310 Genetic Analyzer (Applied Biosystems) and
GENOTYPER software.
Probes
To characterize the deletions by Southern blot anal-
ysis, the following probes were used: 71.19.12HR (Sai-
toh et al. 1996), YR9AB (Dittrich et al. 1994), and kb19,
a 500-bp genomic fragment that maps ∼8 kb proximal
to YR9AB (K. Buiting, unpublished data). Methylation
analysis was performed with probe PW71B, for the
D15S63 locus, and with kb17 (Buiting et al. 1998), for
the SNRPN exon 1 region.
Results
In the course of routine diagnostic testing, we found
a German patient (We) with PWS and an apparently
homozygous deletion for PW71 (D15S63; fig. 1). Re-
peated Southern blot hybridizations with PW71 never
gave a signal with the patient’s DNA, whereas control
probes for other loci did (data not shown), thus dem-
onstrating the integrity of the DNA sample. Interestingly,
the two healthy brothers and their healthymother lacked
a maternal band—that is, showed an “AS” pattern. Mi-
crosatellite studies (fig. 2) and quantitative Southern blot
hybridizations with PW71 (data not shown) revealed
that the patient has a common large deletion on his
paternal chromosome and a small deletion spanning the
PW71 locus on his maternal chromosome. The meth-
ylation analysis suggested that the small deletion was
also present in the two healthy sibs and in their mother.
Knowing about this deletion, we investigated other
families with an unusual PW71 result. As shown in table
1, we identified four individuals with an abnormal
PW71-methylation pattern but with a normal SNRPN-
methylation pattern. This group of individuals included
two patients with unspecific MR (63 and Pl) and one
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Figure 3 Identification of the proximal and the distal deletion
breakpoints by Southern blot analysis. The junction fragments are
indicated by an asterisk (*).
Table 1
Patients with Unusual PW71 Results
PATIENT
CLINICAL
DIAGNOSISa COUNTRY
METHYLATION PATTERNb
PW71 SNRPN
We PWS Germany Homozygous deletion “PWS”
63 MR Israel “PWS” Normal
Pl MR Germany “PWS” Normal
B AS? England “PWS” Normal
221 AS? Israel “AS” Normal
a ? = Clinical diagnosis uncertain.
b “PWS” = lack of paternal band; “AS” = lack of maternal band.
patient suspected of having AS (B), who, surprisingly,
lacked the paternal PW71 band—that is, showed a
“PWS” pattern. Patient 221, who was suspected of hav-
ing AS, did show an “AS” methylation pattern with
PW71, but subsequent molecular work-up of the patient
revealed a normal SNRPN-methylation pattern. We rea-
soned that the findings in these four patients may also
be explained by a PW71 deletion and set out to inves-
tigate the deletion at the nucleotide level.
Characterization of the Deletion
First, we performed Southern blot hybridizations with
probes flanking PW71. In HindIII-digested DNA from
patients We, 63, and Pl, we detected a putative deletion-
junction fragment of 15 kb, with probes 71.19.12 HR
and YR9AB (see fig. 3; patients B and 221 had not yet
been identified at this stage of our study).
Refined restriction analysis of DNA from the eldest
brother of patient We (HW) revealed that the proximal
deletion breakpoint maps inside a 3.6-kb BglII/PstI frag-
ment (HWNFC), between the anonymous markers
71.19.12HR and PW71, and that the distal breakpoint
lies in a 2.5-kb BamHI/BglII fragment (HWNFT), be-
tween the anonymous markers kb19 (cen) and YR9AB
(tel). Interestingly, the distal breakpoint of the deletion
maps within a previously reported 1.5-kb insertion/de-
letion element, which represents a neutral DNA poly-
morphism (Dittrich et al. 1994; Gabriel et al. 1994). On
the basis of these data, the deletion was estimated to
span ∼28 kb (fig. 4).
To analyze the deletion at the nucleotide level, we
subcloned the 15-kb HindIII junction fragment from
HW and identified one positive phage clone (lHW42).
Since a BglII site flanks HWNFC (3.6 kb) at its cen-
tromeric end and flanksHWNFT (2.5 kb) at its telomeric
end, we subcloned the two BglII fragments of lHW42
that were !6.1 kb (HWAF1, 0.9 kb, and HWAF2, 0.8
kb).
Sequence comparisons of clones HWAF1, HWAF2,
HWNFT, and HWNFC revealed that HWAF2 represents
the junction fragment. HWAF2 contains—from centro-
mere to telomere—a 50-bp single-copy sequence, a par-
tial Alu sequence, a complete Alu sequence, two partial
Alu sequences and a 216-bp single-copy sequence. Se-
quencing of HWNFC, HWNFT, and HWAF2 with spe-
cific primers that recognize the centromeric (primer
HWs) and telomeric (primer HWp) single-copy sequence
of HWAF2 revealed that all three fragments are identical
over an 18-bp interval (see fig. 4). These data suggest
that a recombination event that led to the deletion of
28 kb in individual HW has occurred in an 18-bp in-
terval that starts at nucleotide position 205 of HWAF2
and that is located in the complete Alu- sequence.
To determine whether the junction fragments in all
five families are identical, we performed PCR analysis
using genomic DNA and specific primers flanking the
breakpoints (primers HWs and HWp, see above). As
shown in figure 5, a 612-bp fragment was amplified in
all individuals previously identified as carrying the de-
letion. Sequence analysis of the fragments revealed com-
plete sequence identity in all cases, and therefore the five
families have the same 28-kb deletion.
Frequency of the Deletion
To determine the frequency of the PW71 deletion,
1,000 unrelated individuals were investigated. Fifty-
seven individuals were studied, by Southern blot anal-
ysis, for the presence of the 15-kb HindIII junction frag-
ment. The other individuals (943) were screened by PCR
with primers HWs and HWp. To check for the integrity
of the genomic DNA, control primers for a chromosome
8 locus (O. Schmidt et al., personal communication)
were included in the PCR. None of the investigated in-
dividuals had the 28-kb deletion.
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Figure 4 A, Genomic map of the PW71/SNRPN region, showing the normal allele and the deletion allele. B, Partial sequence of HWNFC
and HWNFT fragments, which contain the proximal and distal deletion-breakpoint region, respectively, and the deletion junction fragment.
The recombination has occurred between two Alu repeats within a stretch of 18 bp. Divergent nucleotides are underlined.
Haplotype Analysis
To determine whether the deletion occurred on a com-
mon ancestral haplotype, we performed microsatellite
analysis with markers from the PWS/AS region (fig. 2).
Interestingly, in families We and 63, the affected chro-
mosomes share alleles at four loci flanking the dele-
tion (D15S543 and D15S817 at the proximal side and
D15S128 and D15S1234 at the distal side). The
D15S543/D15S817 subhaplotype was also found in
family B, and, in families Pl and 221, the sameD15S128
allele that was seen in We and 63 was found.
Discussion
Here we have described the finding of a 28-kb deletion
spanning the PW71 locus on chromosome 15 in five
different families. Partial sequence analysis revealed that
the deletion arose by Alu-Alu recombination between an
Alu repeat inside a polymorphic insertion/deletion ele-
ment and another Alu-repeat 28-kb centromeric. The
identity of the deletion breakpoints suggests that it rep-
resents a rare neutral variant. The frequency of this var-
iant appears to be !.001, at least in Germany, North
America, and Australia. This estimate is based on the
following findings. First, there are three extensive stud-
ies describing a comparison between the PW71- and
SNRPN-methylation patterns (Kubota et al. 1996; Buch-
holz et al. 1997; Zeschnigk et al. 1997). No discrepancy
was observed between the methylation patterns at the
two loci in the 690 patients with either PWS or AS and
normal controls tested in these studies, suggesting that
none of the individuals tested carried the deletion. In
PWS and AS patients with uniparental heterodisomy, the
methylation pattern may mask such a deletion, but these
patients represent the minority of the investigated in-
dividuals. Second, we did not find the deletion in 1,000
unrelated individuals.
The haplotype data are compatible with a common
ancestral origin of the deletion, in at least two families.
In view of the large genetic distance between the avail-
able markers in the PWS/AS region, however, it cannot
be excluded that the other three families, who have at
least one allele in common with the other two families,
are also related to this putative common ancestor. Al-
though two families are from Israel and the mother of
patient We has Jewish ancestors, the data are not suf-
ficient to determine whether the deletion is of Jewish
origin.
Although in family 221 the inheritance pattern of the
deletion appears to be like that of an imprinting mu-
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Figure 5 Deletion junction PCR. Individuals carrying the 28-kb deletion are positive for a 612-bp PCR product.
tation, and although the deletion affects one of the al-
ternative start exons of the putative IC transcripts (exon
u1A, previously designated “BD1A” [Dittrich et al.
1996b; Fa¨rber et al. 1999]), there is no evidence that
the deletion impairs imprinting in this region. (1) The
28-kb deletion does not overlap with the smallest regions
of deletion overlap in AS (Ohta et al. 1999a) and PWS
(Ohta et al. 1999b), which map ∼50 and ∼85 kb more
telomeric, respectively. (2) The identification of the de-
letion in patients suspected of having either PWS or AS
is most likely due to an ascertainment bias—other pa-
tients would not have been tested for methylation at this
locus—and does not imply a causal relationship between
the deletion and the disease. There are six deletion car-
riers with a normal phenotype who inherited the deletion
from the mother and eight deletion carriers who inher-
ited the deletion from the father. It is possible that the
IC transcripts are not necessary for imprinting or that
expression from the remaining start exon (u1B, previ-
ously designated “BD1B”), which is not affected in these
individuals, is sufficient for the proposed role of the IC
transcripts in the imprinting process.
Although the PW71 deletion represents a very rare
variant, our findings have important implications for
routine diagnostic testing of patients suspected of having
either PWS or AS. The deletion may lead to false-positive
PW71-methylation results, and it is recommended that
diagnostic laboratories that have obtained unexpected
or unusual results test their samples for the presence of
the deletion, by using the deletion-junction PCR assay
described in this report. In contrast to the PW71 dele-
tion, all deletions including the SNRPN promoter/exon
1 region appear to be associated with an imprinting de-
fect (Sutcliffe et al. 1994; Buiting et al. 1995; Saitoh et
al. 1996; Ohta et al. 1999b). Therefore, false-positive
methylation results at this locus are less likely, unless
there are technical problems with either the NotI digest
or the methylation-specific PCR. Although we now pre-
fer the methylation-specific PCR analysis of SNRPN, it
may be necessary to test both PW71 and SNRPN. This
is because we have recently identified two patients with
a normal SNRPN-methylation pattern but a truly ab-
normal methylation pattern at PW71 and other differ-
entially methylated sites in the region (K. Buiting and B.
Horsthemke, unpublished data).
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